Fig 1.
Theoretical model of clinical outcome production in HIV infection treatment.
Fig 2.
Distribution of time to VS, in days, Qualiaids-Brazil Cohort, 2015–2018 (N = 128,360).
Fig 3.
SUS HIV treatment facilities and number of individuals included in the cohort who initiated ART in 2015–2018, categorized by macro-region of the country.
Qualiaids-Brazil Cohort, 2022 (N = 941).
Table 1.
Descriptive analysis and bivariate analysis of the time from treatment initiation to VS, according to individual variables.
Qualiaids-Brazil Cohort, 2015–2018 (N = 128,360).
Table 2.
Bivariate analysis of the time between treatment initiation and VS, according to facility-related variables.
Qualiaids-Brazil Cohort, 2015–2018 (N = 128,360).
Table 3.
Results of hierarchically adjusted multilevel models for time to VS, according to individual and facility-related characteristics, Qualiaids-Brazil Cohort, 2015–2018 (N = 128,360).
Table 4.
Results of the random-effects analysis of models null through 3, Qualiaids-Brazil Cohort, 2015–2018 (N = 128,360).